AGA Family of Websites:
AGA Journals
AGA Journals
AGA University
AGA University
AGA University
AGA Research Foundation
AGA University
AGA Community
AGA University
AGA Job Board
Small Talks, Big GI Topics
  February 3, 2021

20+ insights to improve your IBD patient care

On the heels of the 2021 Crohn’s & Colitis Congress®, Dr. David Rubin shares highlights from the meeting and how to bring them back to your patients.
Share on facebook
Share on twitter
Share on linkedin
Share on email

In this episode of the AGA podcast, Small Talk, Big Topicshosts Drs. Matthew Whitson and CS Tse interview Dr. David Rubin, professor and chief of the section of gastroenterology, hepatology and nutrition at the University of Chicago. The conversation takes place just after the 2021 Crohn’s & Colitis Congress, of which Dr. Rubin served as co-chair, and focuses in large part on the congress and its importance for the field of gastroenterology. Matthew and CS talk with Dr. Rubin about events of this year’s virtual Congress, his own mentors, the relation between inflammatory bowel disease (IBD) and COVID-19, what is on the horizon of IBD treatment, and more!

As the conversation gets underway, Dr. Rubin introduces himself and the Crohn’s & Colitis Congress. The Congress is a joint project of AGA and the Crohn’s & Colitis Foundation, and this year’s meeting — held virtually due to the ongoing COVID-19 pandemic — provided research updates, networking opportunities and career development. The meeting was centered on several themes, the first of which was the pandemic. In general, Dr. Rubin says, COVID-19 outcomes for patients with IBD are not worse than those of the general population, with the only exceptions pertaining to individuals on certain medications. Further, he addresses concerns over therapy continuity through the pandemic, and advises IBD patients to receive their COVID-19 vaccine whenever possible.

Besides COVID-19, the Congress covered a variety of other topics, such as advances in clinical care. These include emerging tools for monitoring based on objective measures, as well as new medications and fine-tuned ways of using existing medications. Dr. Rubin explains how clinicians need to combine science and art to counter both misinformation and a cultural trend that trusts too much in anecdotes. He further shares insight on IBD and pediatrics, the concept of wellness, diet and its impact on the microbiome, and several other topics the meeting sessions covered. Listeners can still access Congress recordings, and Dr. Rubin encourages them — whether advanced or early in their careers — to get involved in such GI community opportunities as this to learn, network and collaborate. In closing, he passes on wisdom he has received to young gastroenterologists and trainees, and explains why listeners should not adhere to dogma. 

Follow Dr. David Rubin, and connect with him at
Connect with Dr. Rubin on Twitter and his lab group website.
Follow Matthew on Twitter.
Follow Nina on Twitter.
Follow CS on Twitter.
Follow AGA on Twitter.
Email at

Subscribe & listen to
Small Talk, Big Topics
Discussion Icon

Discuss this news

Share this article in the AGA Community, your member-only platform for sharing your thoughts and ideas with your colleagues.

Not a member? Join AGA.

By using this site, you agree to our updated Privacy Policy.